Abstract

Autologous airway epithelial cells have been used in clinical tissue‐engineered airway transplantation procedures with a view to assisting mucosal regeneration and restoring mucociliary escalator function. However, limited time is available for epithelial cell expansion due to the urgent nature of these interventions and slow epithelial regeneration has been observed in patients. Human airway epithelial cells can be expanded from small biopsies or brushings taken during bronchoscopy procedures, but the optimal mode of tissue acquisition from patients has not been investigated. Here, we compared endobronchial brushing and endobronchial biopsy samples in terms of their cell number and their ability to initiate basal epithelial stem cell cultures. We found that direct co‐culture of samples with 3T3‐J2 feeder cells in culture medium containing a Rho‐associated protein kinase inhibitor, Y‐27632, led to the selective expansion of greater numbers of basal epithelial stem cells during the critical early stages of culture than traditional techniques. Additionally, we established the benefit of initiating cell cultures from cell suspensions, either using brushing samples or through enzymatic digestion of biopsies, over explant culture. Primary epithelial cell cultures were initiated from endobronchial biopsy samples that had been cryopreserved before the initiation of cell cultures, suggesting that cryopreservation could eliminate the requirement for close proximity between the clinical facility in which biopsy samples are taken and the specialist laboratory in which epithelial cells are cultured. Overall, our results suggest ways to expedite epithelial cell preparation in future airway cell therapy or bioengineered airway transplantation procedures.

Highlights

  • Airway tissue engineering has seen the development of cell-scaffold solutions for otherwise intractable human disease and has seen clinical translation in compassionate cases (Badylak et al, 2012)

  • The optimal method to isolate autologous epithelial cells from patient biopsy samples remains unclear. This has been achieved by explant culture of endobronchial biopsy samples in bronchial epithelial growth medium (BEGM) (Butler et al, 2016) but we reasoned that initiation of cultures would be improved using the 3T3+Y protocol

  • In vitro expansion of human airway epithelial cells has been reported from both endobronchial brushings (Kelsen et al, 1992) and endobronchial biopsies, either as explants or digested to obtain a cell suspension (Goulet et al, 1996)

Read more

Summary

Introduction

Airway tissue engineering has seen the development of cell-scaffold solutions for otherwise intractable human disease and has seen clinical translation in compassionate cases (Badylak et al, 2012). This method has clear advantages over the time-consuming derivation of airway epithelial cells from pluripotent stem cells and conventional cell culture using bronchial epithelial growth medium (BEGM) for basal cell expansion, owing to its capability to expand autologous primary cells from living patients in meaningful numbers.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.